Blood Management Program in the Post - Operative Period.

July 31, 2015 updated by: PAMELABERNI, Arcispedale Santa Maria Nuova-IRCCS

Blood Management Program: Appropriateness of Transfusion Therapy in the Post - Operative Period.

A care path in the field of transfusion medicine was creates at ASMN - IRCCS addressed to patients undergoing complex surgical procedures.

Study Overview

Detailed Description

This pathway is called Blood Management Program (BMP).

The implementation of this process should improve transfusion therapy in the peri-operative period in order to:

  • correct the transfusional approach to surgical patients
  • optimize the management of transfusional resources (red blood cells, plasma, platelets)
  • optimize the management of plasma derivatives, drugs and techniques designed to limit the use of homologous blood

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Emilia Romagna
      • Reggio Emilia, Emilia Romagna, Italy, 42123
        • Recruiting
        • IRCCS-Arcispedale Santa Maria Nuova
        • Contact:
        • Principal Investigator:
          • Di Bartolomeo Erminia, Physician

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patients undergoing complex surgical procedures

Description

Inclusion Criteria:

-All patients undergoing complex surgical procedures

Exclusion Criteria:

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Evaluation of therapeutic appropriateness for Red Cells - Plasma - Platelets transfusion: comparison between prospective vs. retrospective data in ASMN ,Reggio Emilia (Italy)
Time Frame: 24 months
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Erminia Di Bartolomeo, MD, Asmn-Irccs

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2014

Primary Completion (Anticipated)

December 1, 2015

Study Completion (Anticipated)

January 1, 2016

Study Registration Dates

First Submitted

May 26, 2014

First Submitted That Met QC Criteria

May 28, 2014

First Posted (Estimate)

May 29, 2014

Study Record Updates

Last Update Posted (Estimate)

August 3, 2015

Last Update Submitted That Met QC Criteria

July 31, 2015

Last Verified

June 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • BMP - TRASFU1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Excessive Amount of Blood / Fluid Transfusion

3
Subscribe